Groupe ProductLife S.A.S.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Groupe ProductLife S.A.S. - overview
Established
1993
Location
Suresnes, -, France
Primary Industry
Outsourcing
About
Groupe ProductLife S. A. S. , based in France, specializes in regulatory compliance consulting for the pharmaceutical, biotechnology, and healthcare sectors, facilitating market access and supporting product lifecycle management.
Founded in 1993 in Suresnes, France, Groupe ProductLife S. A. S. provides regulatory consulting services, primarily to pharmaceutical and healthcare companies.
The firm has completed a total of 3 deals, with the most recent deal occurring on May 23, 2024. The company is led by CEOs Adam Sherlock and Erick Gaussens. Groupe ProductLife specializes in regulatory compliance consulting for the pharmaceutical, biotechnology, and healthcare sectors. They offer a comprehensive suite of services throughout the medical product lifecycle, including drug development, regulatory affairs, quality compliance, and post-marketing surveillance.
Their core offerings include product development strategies, market access consulting, and life cycle management solutions, assisting clients in navigating complex regulatory landscapes across North America, Europe, and parts of Asia. Groupe ProductLife operates on a B2B transaction model focused on consulting services for pharmaceutical and healthcare companies. Their revenue structure includes service agreements that may consist of fixed project fees, retainer agreements, and performance-based incentives tied to successful regulatory approvals. While specific pricing details are undisclosed, their flagship services are essential for clients' successful market access and product launches.
In May 2024, Oakley Capital invested in Groupe ProductLife S. A. S. , with financial terms undisclosed, and 21Invest reinvested in the company.
The investment will support the company's international expansion and enhance its investment in artificial intelligence. Future growth plans include the development of new products and services aimed at improving compliance strategies, with targeted expansions into emerging markets anticipated in the next year.
Current Investors
21 Invest
Primary Industry
Outsourcing
Sub Industries
Consulting Services, BPO Services
Website
www.productlifegroup.com/
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Groupe ProductLife S.A.S. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | HERAX Life Science | - | ||||||||
| Add-on, Corporate Carve Out | Completed | Stragen Services SAS | - | ||||||||
| Add-on | Completed | Callisto Pharma Group | - | ||||||||
| Add-on | Completed | Halloran Consulting Group, Inc. | - | ||||||||
| Add-on | Completed | IntiQuan AG | - |
Displaying 1 - 5 of 23
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.